These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Impaired anti-inflammatory activity of PPARγ in the salivary epithelia of Sjögren's syndrome patients imposed by intrinsic NF-κB activation. Vakrakou AG; Polyzos A; Kapsogeorgou EK; Thanos D; Manoussakis MN J Autoimmun; 2018 Jan; 86():62-74. PubMed ID: 29033144 [TBL] [Abstract][Full Text] [Related]
25. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome. Pertovaara M; Silvennoinen O; Isomäki P Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842 [TBL] [Abstract][Full Text] [Related]
26. MiR-34a promotes mitochondrial pathway of apoptosis in human salivary gland epithelial cells by activating NF-κB signaling. He F; Yu J; Ma S; Zhao W; Wang Q; He H; Zhang M; Wang J; Lu Z Arch Biochem Biophys; 2024 Aug; 758():110063. PubMed ID: 38880321 [TBL] [Abstract][Full Text] [Related]
27. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Llorente L; Richaud-Patin Y; Fior R; Alcocer-Varela J; Wijdenes J; Fourrier BM; Galanaud P; Emilie D Arthritis Rheum; 1994 Nov; 37(11):1647-55. PubMed ID: 7980676 [TBL] [Abstract][Full Text] [Related]
28. 1,25-dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IκBα via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells. Song Y; Hong J; Liu D; Lin Q; Lai G Scand J Immunol; 2013 Feb; 77(2):109-16. PubMed ID: 23126502 [TBL] [Abstract][Full Text] [Related]
29. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome. Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497 [TBL] [Abstract][Full Text] [Related]
30. Activation of the interferon pathway in peripheral blood of patients with Sjogren's syndrome. Kimoto O; Sawada J; Shimoyama K; Suzuki D; Nakamura S; Hayashi H; Ogawa N J Rheumatol; 2011 Feb; 38(2):310-6. PubMed ID: 21078725 [TBL] [Abstract][Full Text] [Related]
31. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome. Zilahi E; Tarr T; Papp G; Griger Z; Sipka S; Zeher M Immunol Lett; 2012 Jan; 141(2):165-8. PubMed ID: 22033216 [TBL] [Abstract][Full Text] [Related]
32. Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis. Nezos A; Mavragani CP J Immunol Res; 2015; 2015():754825. PubMed ID: 26550578 [TBL] [Abstract][Full Text] [Related]
33. Increase of Intracellular BAFF in B Cells of Sjögren's Patients Is Not Affected by Decrease of BAFFR. Krejsek J; Koláčková M; Lindrová I; Slezák R; Andrýs C Acta Medica (Hradec Kralove); 2015; 58(1):25-31. PubMed ID: 26454804 [TBL] [Abstract][Full Text] [Related]
34. Study of clinical factors, focus score, lymphocyte type and NF-κB pathway in Sjögren's syndrome. Ono J; Toya S; Ogura I; Okada Y Odontology; 2023 Jan; 111(1):207-216. PubMed ID: 35915313 [TBL] [Abstract][Full Text] [Related]
35. Grp78 regulates NLRP3 inflammasome and participates in Sjogren's syndrome. He J; Xu M; Chen Y; Wu S Int Immunopharmacol; 2024 Oct; 140():112815. PubMed ID: 39088921 [TBL] [Abstract][Full Text] [Related]
36. Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity. Pauley KM; Stewart CM; Gauna AE; Dupre LC; Kuklani R; Chan AL; Pauley BA; Reeves WH; Chan EK; Cha S Eur J Immunol; 2011 Jul; 41(7):2029-39. PubMed ID: 21469088 [TBL] [Abstract][Full Text] [Related]
37. A role for lymphotoxin in primary Sjogren's disease. Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683 [TBL] [Abstract][Full Text] [Related]
38. Expression of Nod-like Receptors and Clinical Correlations in Patients With Dry Eye Disease. Kim YH; Li Z; Cui L; Li Y; Yoon HJ; Choi W; Lee JB; Liu Z; Yoon KC Am J Ophthalmol; 2019 Apr; 200():150-160. PubMed ID: 30653959 [TBL] [Abstract][Full Text] [Related]
39. The nuclear-factor kappaB pathway is activated in pterygium. Siak JJ; Ng SL; Seet LF; Beuerman RW; Tong L Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):230-6. PubMed ID: 20811049 [TBL] [Abstract][Full Text] [Related]
40. [Efficay Observation of Xinfeng Capsule for Treating 58 Cases of Sjogren's Syndrome]. Zhu FB; Liu J; Fang L; Zhang PH; Tan B Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Nov; 36(11):1323-1328. PubMed ID: 30641625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]